Evaluation of preclinical atherosclerosis in chronic myeloid patients continuously treated with tyrosine kinase inhibitors
31 August 2019 (11:00 - 16:00)
Organised by:
Abstract
About the speaker
Almazov National Medical Research Centre, Saint Petersburg (Russian Federation)
7 More presentations in this session
Access the full session
The Event
ESC Congress 2019
31 August 2019
11:00 CET
